Ning Xu
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Urology top 2%
Papers in
-
- Prostate Cancer Treatment and Research 36
- Prostate Cancer Diagnosis and Treatment 25
- Ferroptosis and cancer prognosis 23
- Renal cell carcinoma treatment 16
- Co-authors
- Xue‐Yi Xue (105 shared papers)Yong Wei (88 shared papers)Qing‐Shui Zheng (90 shared papers)Shao‐Hao Chen (76 shared papers)Yu‐Peng Wu (53 shared papers)Zhi‐Bin Ke (59 shared papers)Zhaochao Xu (7 shared papers)Jin‐Bei Huang (23 shared papers)
- Journals
- Medicine (10 papers)Frontiers in Oncology (5 papers)Journal of Cancer (5 papers)Cancer Medicine (4 papers)Journal of Cancer Research and Clinical Oncology (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ning Xu
359 papers receiving 5.2k citations
Peers
Comparison fields: 5 of 183
- Cancer Research 849
- Urology 249
- Pulmonary and Respiratory Medicine 962
- Molecular Biology 1.7k
- Parasitology 150
Countries citing papers authored by Ning Xu
This map shows the geographic impact of Ning Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Xu more than expected).
Fields of papers citing papers by Ning Xu
This network shows the impact of papers produced by Ning Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Xu. The network helps show where Ning Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 393 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 194 | |
| 2 | 1996 | 192 | |
| 3 | 2009 | 168 | |
| 4 | 2001 | 157 | |
| 5 | 2018 | 133 | |
| 6 | 2003 | 130 | |
| 7 | 1997 | 125 | |
| 8 | 2005 | 121 | |
| 9 | 2021 | 108 | |
| 10 | 2009 | 98 | |
| 11 | 2014 | 95 | |
| 12 | 2018 | 72 | |
| 13 | 2020 | 67 | |
| 14 | 2011 | 52 | |
| 15 | 2019 | 51 | |
| 16 | 2005 | 49 | |
| 17 | 2020 | 48 | |
| 18 | 2019 | 46 | |
| 19 | 2019 | 44 | |
| 20 | 2018 | 42 |
About Ning Xu
Ning Xu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Cancer Research and Oncology, having authored 393 papers that have together received 5.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (36 papers), Prostate Cancer Diagnosis and Treatment (25 papers), Cancer, Lipids, and Metabolism (23 papers), Ferroptosis and cancer prognosis (23 papers), Bladder and Urothelial Cancer Treatments (20 papers), Cancer-related molecular mechanisms research (20 papers), Urological Disorders and Treatments (19 papers) and Renal cell carcinoma treatment (16 papers). The work is most often cited by research in Cancer Research (849 citations), Urology (249 citations), Pulmonary and Respiratory Medicine (962 citations), Molecular Biology (1.7k citations) and Parasitology (150 citations). Ning Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xue‐Yi Xue, Yong Wei, Qing‐Shui Zheng, Shao‐Hao Chen, Yu‐Peng Wu, Zhi‐Bin Ke, Zhaochao Xu, Jin‐Bei Huang, Qinglong Qiao and Yun‐Zhi Lin. Their work appears in journals such as Medicine, Frontiers in Oncology, Journal of Cancer, Cancer Medicine and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.